期刊文献+

脑钠素与非瓣膜性房颤患者血栓形成的关系及抗凝治疗对其的影响 被引量:2

下载PDF
导出
摘要 目的探讨血清脑钠素水平与非瓣膜性房颤患者血栓形成的关系及抗凝治疗对其的影响。方法选取福建医科大学附属协和医院及福建中医药大学附属第二人民医院2014年1月到2015年12月期间门诊及住院的58例非瓣膜性房颤患者,行经食道超声心动图检测患者左心房血栓情况,根据左心房有无血栓,分为观察组(有血栓,28例)和对照组(无血栓,30例),并测定脑钠素水平,抗凝治疗后再次测定脑钠素水平,分析脑钠素和血栓形成的关系。结果与对照组比较,观察组的脑钠素水平高,有显著性差异,P<0.05,有统计学意义。观察组抗凝治疗后脑钠素水平降低,有显著性差异,P<0.05,有统计学意义。结论血清脑钠素为非瓣膜性房颤患者血栓形成的一个预测因子,规则抗凝治疗可使脑钠素水平降低。
出处 《海峡药学》 2016年第7期109-110,共2页 Strait Pharmaceutical Journal
基金 2011年福建省教育厅B类科技项目(JB11079)
  • 相关文献

参考文献10

  • 1张振华,张海波,孟旭.预防心房颤动栓塞事件的治疗现状与进展[J].心肺血管病杂志,2013,32(5):659-662. 被引量:13
  • 2Atrial fibrillation as an independent risk factor for stroke:the Framingham study[J].Stroke,1991,22:983-988.
  • 3Donald M,Thomas JW,Erie PL,et al.Life time risk for development of atrial fibrillation.The framingham heart study[J].Circulation,2004,101:1042-1046.
  • 4Small,blind-ended structure:a review of its echocardiographic evaluation and its clinical role[J].Chest,2005,128(3):1853-1862.
  • 5Camm AJ,Camm CF,Savelieva I.Medical treatment of atrial fibrillation[J].J Cardiovasc Med(Hagerstown),2012,13(2):97-107.
  • 6Tuinenburg AE,Brundel BJ,Van GI,et al.Gene expression of the natriuretic peptide system inatrial tissue of patients with paroxysmal and persistent atrial fibrillation[J].J Cardiovasc Electrophysiol,1999,10(6):827.
  • 7Donal E,Yamada H,Leclercq C,et al.The left atrial appendage,a small,blind-ended structure:a review of its echocardiographic evaluation and its clinical role[J].Chest,2005,128(3):1853-1862.
  • 8Camm AJ,Camm CF,Savelieva I.Medical treatment of atrial fibrillation[J].J Cardiovasc Med(Hagerstown),2012,13(2):97-107.
  • 9Inoue S,Murakami Y,Sano K,et al.Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation[J].J Card Fail,2000,6(2):92-96.
  • 10Ochiumi Y,Kagawa E,Kato M,etl.Usefulness of brain natriuretic peptide for predicting left atrial appendage thrombus in patients with unanticoagulated nonvalvular persistent atrial fibrillation[J].J Arrhythm,2015 Oct,31(5):307-312.

二级参考文献32

  • 1史爱武,陆凤翔,许迪,姚静,王晓伟,盛艳辉,杨荣,李世杰,曹克将,孔祥清.经胸超声心动图评价左心耳封堵术对猪左心房功能及二尖瓣、肺静脉血流动力学的影响[J].中华医学超声杂志(电子版),2007,4(2):67-69. 被引量:3
  • 2Heeringa J. Atrial fibrillation: is the prevalence rising? Eu- ropace,2010,12:451-452.
  • 3Zhang S. Atrial fibrillation in China's Mainland: epidemiology and current management. Heart ,2009,95 : 1052-1055.
  • 4Wolf PA,Abbott RD, Kannel WB, et al. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke, 1991, 22:983-988.
  • 5Villani GQ, Piepoli PE, VilIaniPE, et al. Anticoagulationin atrial fibrillation; what is certain and what is to come. Eur Heart J, 2003, (Suppl) :45-50.
  • 6Veinot JP, Harrity PJ, Gentile F, et al. Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy hearts;implications for echocardiographic examina- tion. Circulation, 1997,96 : 3112 -3115.
  • 7Kamath S, Blann AD, Chin BS, et al. Platelet activation, haemo- rheology and thrombogenesis in acute atrialfibrillation: a compari- son with permanent atrial fibrillation, Heart, 2003,89: 1093- 1095.
  • 8Agarwal S, Hachamovitch R, Menon V, et al. Current trial-asso- ciated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: A Meta-analysis. Arch Intern Med ,2012,172:623-631.
  • 9Connolly S J, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarinpatients with atrial fibrillation. N Engl J Med, 2009, 361:1139-1151.
  • 10Eikelboom JW, Wallentin L, Connolly S J, et al. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: An analysis of the ran- domized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation, 2011,123 : 2363-2372.

共引文献12

同被引文献9

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部